Immunic, Inc.IMUXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank21
3Y CAGR-47.5%
5Y CAGR-34.4%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-47.5%/yr
vs +68.2%/yr prior
5Y CAGR
-34.4%/yr
Recent deceleration
Acceleration
-115.7pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$15.48M-56.6%
2024$35.67M-23.6%
2023$46.67M-56.3%
2022$106.75M+22.9%
2021$86.86M-31.8%
2020$127.45M+334.0%
2019$29.37M+120.4%
2018$13.32M-76.6%
2017$56.90M-5.2%
2016$59.99M-